75N93026C00007
Definitive Contract
Overview
Government Description
Development of radiation/nuclear medical countermeasures (MCMS) and biodosimetry devices. 7-1/2026 to 6/30/2026. DAP-NCAP-00000073.
Awardee
Awarding / Funding Agency
Place of Performance
New York, NY 10013 United States
Pricing
Cost Plus Fixed Fee
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
7
Related Opportunity
None
Ceramedix Holding was awarded
Definitive Contract 75N93026C00007 (75N930-26-C-00007)
worth up to $4,500,000
by the National Institute of Allergy and Infectious Diseases
in July 2026.
The contract
has a duration of 3 years and
was awarded
full & open
with
NAICS 541714 and
PSC AN12
via direct negotiation acquisition procedures with 18 bids received.
As of today, the Definitive Contract has a total reported backlog of $3,000,000.
Status
(Open)
Last Modified 6/29/26
Period of Performance
7/1/26
Start Date
6/30/27
Current End Date
6/30/29
Potential End Date
Obligations and Backlog
$1.5M
Total Obligated
$1.5M
Current Award
$4.5M
Potential Award
$0.0
Funded Backlog
$3.0M
Total Backlog
Award Hierarchy
Definitive Contract
75N93026C00007
Subcontracts
Activity Timeline
People
Suggested agency contacts for 75N93026C00007
Competition
Number of Bidders
18
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
JLZSJRJVKJ49
Awardee CAGE
7SUF5
Agency Detail
Awarding Office
75N930 NATIONAL INSTITUTES OF HEALTH NIAID
Funding Office
75N930
Created By
hhslanglin
Last Modified By
hhscdmp
Approved By
hhscdmp
Legislative
Legislative Mandates
None Applicable
Performance District
NY-10
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Representative
Dan Goldman
Modified: 6/29/26